Remarkably, RGS2 gene expression was also upregulated in the majority of breast cancers examined, suggesting that dysfunction in the pathway or pathways regulated by RGS2 in the breast is an obligate event in breast cancer development. The gene discussed is RGS2; the disease is breast carcinoma.